Home > Qtrly Results > OXYGENTA PHARMACEUTICAL

OXYGENTA PHARMACEUTICAL
Quarterly Results Analysis [Dec2025]

OXYGENTA PHARMACEUTICAL is part of below Screeners ↓
Top Undervalued Small Cap Stocks
AD     Remove this Ad

OXYGENTA PHARMACEUTICAL Quarterly Results

Standalone Dec2025
UnAudited
Sep2025
UnAudited
Jun2025
UnAudited
Mar2025
UnAudited
Dec2024
UnAudited
Sep2024
UnAudited
Jun2024
UnAudited
Mar2024
UnAudited
Revenues ₹34 Cr ₹14 Cr ₹15 Cr ₹49 Cr ₹34 Cr ₹15 Cr ₹13 Cr ₹11 Cr
Expenses ₹38 Cr ₹19 Cr ₹22 Cr ₹51 Cr ₹38 Cr ₹16 Cr ₹14 Cr ₹12 Cr
Operating Income ₹-4 Cr ₹-5 Cr ₹-7 Cr ₹-2 Cr ₹-4 Cr ₹-1 Cr ₹-2 Cr ₹-2 Cr
Other Income ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr
Interest ₹1 Cr ₹1 Cr ₹1 Cr ₹2 Cr ₹0 Cr ₹1 Cr ₹0 Cr ₹1 Cr
Depreciation ₹1 Cr ₹1 Cr ₹1 Cr ₹0 Cr ₹1 Cr ₹1 Cr ₹1 Cr ₹1 Cr
Profit Before Tax ₹-6 Cr ₹-6 Cr ₹-8 Cr ₹-4 Cr ₹-5 Cr ₹-3 Cr ₹-3 Cr ₹-3 Cr
Profit After Tax ₹-5 Cr ₹-5 Cr ₹-6 Cr ₹-2 Cr ₹-4 Cr ₹-3 Cr ₹-1 Cr ₹8 Cr
EPS ₹-1.31 ₹-1.33 ₹-1.65 ₹-0.58 ₹-1.06 ₹-0.80 ₹-0.38 ₹2.39
Industry Peers & Returns1W1M1Y
OXYGENTA PHARMACEUTICAL 2.7% 5.7% -23.1%
SUN PHARMACEUTICAL INDUSTRIES 5.7% -3.3% -2.2%
DIVIS LABORATORIES 1.6% -7.6% 8.6%
CIPLA 0.5% -12.9% -10.4%
TORRENT PHARMACEUTICALS -0.5% 0.9% 23.6%
DR REDDYS LABORATORIES 5.3% -0.9% 1.9%
MANKIND PHARMA -0.5% -7.1% -14.3%
ZYDUS LIFESCIENCES 3% -2.8% -6.7%
LUPIN 3.7% 3% 5.5%

OXYGENTA PHARMACEUTICAL Quarterly Revenues

Revenues
Q-o-Q

138.18 %

Y-o-Y

0.70 %

Quarters Revenues % Change
Dec2025 ₹34 Cr
138.18
Sep2025 ₹14 Cr
-5.87
Jun2025 ₹15 Cr
-69.40
Mar2025 ₹49 Cr
46.81
Dec2024 ₹34 Cr
128.36
Sep2024 ₹15 Cr
16.91
Jun2024 ₹13 Cr
19.61
Mar2024 ₹11 Cr -

OXYGENTA PHARMACEUTICAL Quarterly Operating Profit

Operating Profit
Q-o-Q

Negative

Y-o-Y

Negative

Quarters Operating Profit % Change
Dec2025 ₹-4 Cr
Negative
Sep2025 ₹-5 Cr
Negative
Jun2025 ₹-7 Cr
Negative
Mar2025 ₹-2 Cr
Negative
Dec2024 ₹-4 Cr
Negative
Sep2024 ₹-1 Cr
Negative
Jun2024 ₹-2 Cr
Negative
Mar2024 ₹-2 Cr -
Operating Margins
Q-o-Q

Negative

Y-o-Y

Negative

Quarters Operating Margin% % Change
Dec2025 -12.01%
Negative
Sep2025 -32.51%
Negative
Jun2025 -45.13%
Negative
Mar2025 -3.4%
Negative
Dec2024 -11.48%
Negative
Sep2024 -9.64%
Negative
Jun2024 -14.14%
Negative
Mar2024 -15.31% -

OXYGENTA PHARMACEUTICAL Quarterly Profit After Tax

Profit After Tax(PAT)
Q-o-Q

Negative

Y-o-Y

Negative

Quarters Profit After Tax % Change
Dec2025 ₹-5 Cr
Negative
Sep2025 ₹-5 Cr
Negative
Jun2025 ₹-6 Cr
Negative
Mar2025 ₹-2 Cr
Negative
Dec2024 ₹-4 Cr
Negative
Sep2024 ₹-3 Cr
Negative
Jun2024 ₹-1 Cr
Negative
Mar2024 ₹8 Cr -
PAT Margins
Q-o-Q

Negative

Y-o-Y

Negative

Quarters PAT Margin(%) % Change
Dec2025 -14.27 %
Negative
Sep2025 -34.61 %
Negative
Jun2025 -40.34 %
Negative
Mar2025 -4.35 %
Negative
Dec2024 -11.66 %
Negative
Sep2024 -19.35 %
Negative
Jun2024 -10.81 %
Negative
Mar2024 75.96 % -

OXYGENTA PHARMACEUTICAL Quarterly Earnings Per Share (EPS)

EPS
Q-o-Q

Negative

Y-o-Y

Negative

Quarters EPS % Change
Dec2025 ₹-1.31
Negative
Sep2025 ₹-1.33
Negative
Jun2025 ₹-1.65
Negative
Mar2025 ₹-0.58
Negative
Dec2024 ₹-1.06
Negative
Sep2024 ₹-0.8
Negative
Jun2024 ₹-0.38
Negative
Mar2024 ₹2.39 -

You may also like the below Video Courses